The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent to Indian drugmaker Aurobindo Pharma last month and issued a statement drawing attention to three recent warning letters sent to active pharmaceutical ingredient (API) repackers.
Izeen Pharma Inc Receives FDA Warning Letter